Formycon Partners With Leukocare For Stable Biosimilar Formulations

Formycon Has Three Biosimilars In Advanced Development

 
• By Dean Rudge
  
Handshake of businessmen
Leukocare will apply its formulation and bioinformatics expertise to Formycon’s “comprehensive development knowhow.” • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products